Integrated metabolomics and lipidomics study of patients with atopic dermatitis in response to dupilumab

BACKGROUND: Atopic dermatitis (AD) is one of the most common chronic inflammatory skin diseases. Dupilumab, a monoclonal antibody that targets the interleukin (IL)-4 and IL-13 receptors, has been widely used in AD because of its efficacy. However, metabolic changes occurring in patients with AD in r...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lishan, Wen, Xueyi, Hou, Yibo, Yang, Yongshi, Song, Wei, Zeng, Yueping, Sun, Jinlyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632449/
https://www.ncbi.nlm.nih.gov/pubmed/36341398
http://dx.doi.org/10.3389/fimmu.2022.1002536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632449/
https://www.ncbi.nlm.nih.gov/pubmed/36341398
http://dx.doi.org/10.3389/fimmu.2022.1002536

Ejemplares similares